These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15231830)

  • 1. Novel mechanism of inhibition of HIV-1 reverse transcriptase by a new non-nucleoside analog, KM-1.
    Wang LZ; Kenyon GL; Johnson KA
    J Biol Chem; 2004 Sep; 279(37):38424-32. PubMed ID: 15231830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism for inhibition of HIV-1 reverse transcriptase.
    Skillman AG; Maurer KW; Roe DC; Stauber MJ; Eargle D; Ewing TJ; Muscate A; Davioud-Charvet E; Medaglia MV; Fisher RJ; Arnold E; Gao HQ; Buckheit R; Boyer PL; Hughes SH; Kuntz ID; Kenyon GL
    Bioorg Chem; 2002 Dec; 30(6):443-58. PubMed ID: 12642128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.
    Auwerx J; North TW; Preston BD; Klarmann GJ; De Clercq E; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):400-6. PubMed ID: 11809865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a molecular mechanism of synergy between nucleoside and nonnucleoside AIDS drugs.
    Basavapathruni A; Bailey CM; Anderson KS
    J Biol Chem; 2004 Feb; 279(8):6221-4. PubMed ID: 14722107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of nucleotide insertion and extension at 8-oxo-7,8-dihydroguanine by replicative T7 polymerase exo- and human immunodeficiency virus-1 reverse transcriptase using steady-state and pre-steady-state kinetics.
    Furge LL; Guengerich FP
    Biochemistry; 1997 May; 36(21):6475-87. PubMed ID: 9174365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses.
    Xia Q; Radzio J; Anderson KS; Sluis-Cremer N
    Protein Sci; 2007 Aug; 16(8):1728-37. PubMed ID: 17656585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological Mg
    Achuthan V; Singh K; DeStefano JJ
    Biochemistry; 2017 Jan; 56(1):33-46. PubMed ID: 27936595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
    Das K; Sarafianos SG; Clark AD; Boyer PL; Hughes SH; Arnold E
    J Mol Biol; 2007 Jan; 365(1):77-89. PubMed ID: 17056061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
    Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
    J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs.
    Maga G; Amacker M; Hübscher U; Gosselin G; Imbach JL; Mathé C; Faraj A; Sommadossi JP; Spadari S
    Nucleic Acids Res; 1999 Feb; 27(4):972-8. PubMed ID: 9927728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
    Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH
    J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of HIV-1 enzyme reverse transcriptase inhibition by the compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid through kinetic and in silico studies.
    Souza TM; Rodrigues DQ; Ferreira VF; Marques IP; da Costa Santos F; Cunha AC; de Souza MC; de Palmer Paixão Frugulhetti IC; Bou-Habib DC; Fontes CF
    Curr HIV Res; 2009 May; 7(3):327-35. PubMed ID: 19442130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO).
    Arion D; Fletcher RS; Borkow G; Camarasa MJ; Balzarini J; Dmitrienko GI; Parniak MA
    Mol Pharmacol; 1996 Nov; 50(5):1057-64. PubMed ID: 8913335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
    Suo Z; Johnson KA
    J Biol Chem; 1998 Oct; 273(42):27250-8. PubMed ID: 9765248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase.
    Painter GR; Almond MR; Mao S; Liotta DC
    Curr Top Med Chem; 2004; 4(10):1035-44. PubMed ID: 15193137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.
    Menéndez-Arias L; Betancor G; Matamoros T
    Antiviral Res; 2011 Nov; 92(2):139-49. PubMed ID: 21896288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.
    Hsiou Y; Ding J; Das K; Clark AD; Boyer PL; Lewi P; Janssen PA; Kleim JP; Rösner M; Hughes SH; Arnold E
    J Mol Biol; 2001 Jun; 309(2):437-45. PubMed ID: 11371163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.